Artificial Intelligence Designs Two Potential Antibiotics to Combat Drug-Resistant Gonorrhoea and MRSA
Tired of too many ads?
Remove Ads
Targeting Resistant Superbugs
Implications for the Future of Antibiotics
Tired of too many ads?
Remove Ads
Next Steps
FAQs:
In a groundbreaking development, researchers at the Massachusetts Institute of Technology (MIT) have harnessed artificial intelligence (AI) to design two new innovative antibiotics capable of fighting drug-resistant superbugs, including gonorrhoea and MRSA . The method makes a significant step forward in addressing the growing global threat caused by antimicrobial resistance (AMR), which has been explained by the World Health Organization as one of the most urgent public health challenges of the 21st century.One of the newly developed antibiotics has shown remarkable progress against MRSA (methicillin-resistant Staphylococcus aureus), a dangerous pathogen responsible for severe hospital-acquired infections. MRSA is notorious for evading standard antibiotics, leading to prolonged illnesses and higher mortality rates.The second compound concentrates on drug-resistant strains of Neisseria gonorrhoeae, the bacterium responsible for gonorrhoea. Rising cases of antibiotic-resistant gonorrhoea have raised serious concerns about treatment failures and broader public health risks.Laboratory tests confirmed that both compounds successfully killed the targeted bacteria, even those resistant to multiple existing medications. While these results are preliminary, they provide a strong base for further preclinical and clinical testing.The successful use of AI in developing these antibiotics signals a new era in drug discovery. By reducing the time and cost involved with developing new drugs, AI could enhance the response to emerging superbugs and other infectious diseases. This is particularly important as the antibiotic pipeline has slowed in recent years, making healthcare systems vulnerable to resistant infections.Experts say that AI-designed antibiotics are not a complete solution but rather an important tool in the ongoing battle against AMR. Complementary strategies, including proper antibiotic stewardship, infection prevention, and global surveillance, remain crucial to handling the spread of resistant bacteria.Researchers aim to advance the new compounds into further preclinical trials to evaluate their safety, efficacy, and side effects in humans. If successful, these antibiotics could provide new treatment for patients affected by resistant infections and save countless lives globally.A1. Superbugs are bacteria resistant to multiple antibiotics, making infections harder to treat. They pose a serious global health risk.A2. AI analyzed vast chemical data to predict molecular structures likely to combat resistant bacteria effectively.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
10 hours ago
- Business Standard
Kerala's 'Cancer free Kannapuram' programme gets recognised by WHO
The Cancer-Free Kannapuram initiative, launched in 2016 in Kerala's Kannapuram gram panchayat, has been officially recognised by the World Health Organization (WHO) for its remarkable impact on early detection and control of cancer. This model, rooted in community participation and effective local leadership, has emerged as a replicable template for similar efforts worldwide. What is the Kannapuram model? The model integrates over a decade of community engagement, mobilising local stakeholders under the Gram Panchayat's leadership alongside technical support from a Comprehensive Cancer Care Centre (CCCC). Phase 1: Sensitisation workshops were held, uniting local self-government representatives, primary health staff, and self-help groups with doctors, to raise awareness and form grassroots committees. A comprehensive door-to-door survey followed, identifying high-risk individuals while also exposing deep-rooted fear and misinformation about cancer. Phase 2: This phase included distributing information, education, and communication (IEC) materials, hosting health exhibitions at community events, organising 'winners meets' where survivors shared experiences to reduce fear. It also featured literary competitions, panel discussions on diet and cancer prevention, kitchen garden promotion, and school campaigns on cancer and tobacco with Parent-Teacher Association support. Phase 3: The gram panchayat launched a breast cancer screening project, starting with a single-day registration drive covering 3,800 homes. A 10-day mega camp followed, screening healthy women over 30 with no breast cancer history. Trained female technicians examined 200–500 women daily. Participants received pamphlets and training on self-examination. Women with positive results were counselled and referred to the CCCC for further tests, supported by a dedicated team that coordinated appointments, travel, and follow-ups, ensuring smooth access to care. Impressive outcomes A staggering 96 per cent of eligible women participated in the screening camp, and the detection rate was 0.96 per 1,000. More tests were required for 6.2 per cent of women, according to the positivity in the screening test and findings of the CBE. The majority of them, making up 84 per cent, had no symptoms. Further assessment participation rate either at the CCCC or elsewhere was 66.5 per cent due to continuous intervention and motivation by the volunteers despite having no symptoms. Why the model succeeded Continuous awareness drives, women-led leadership, and community trust were key to the programme's success. As noted in the WHO South-East Asia Journal of Public Health paper on the initiative, 'In our study, the continuous awareness campaigns led by female members, acceptable and cost-free screening methods, well-organised screening camps with female providers, and the geographically accessible campsite led to increased screening participation. The involvement of the community helped to overcome most of the barriers at large, address the possible mistrust between the health system and the public, and sustain the interventions to achieve the goal.' Kannapuram gram panchayat president Rethi K told Deccan Herald that the initiative's success lay in removing the stigma around cancer and ensuring regular screening camps. "We initiated the programme after it came to our notice that many people in the panchayat were suffering from cancer, especially women, and many were reluctant to rule out suspicions owing to fear and stigma. The awareness camps really helped in addressing these issues. As a result, 96 percent of women above the age of 30 could be screened," she said. The Kannapuram model exemplifies how community-driven health initiatives can transform cancer screening and outcomes. It aligns with the WHO's Global Breast Cancer Initiative, which identifies three key pillars for reducing breast cancer mortality: health promotion and early detection, timely diagnosis, and comprehensive cancer management.
Economic Times
a day ago
- Economic Times
Artificial Intelligence Designs Two Potential Antibiotics to Combat Drug-Resistant Gonorrhoea and MRSA
Researchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including gonorrhoea and MRSA. AI predicted efficient molecular structures, which were validated in laboratory tests. This innovative method could revolutionize antibiotic discovery, providing faster, cost-efficient development of treatments against superbugs and addressing one of the most urgent public health threats. Tired of too many ads? Remove Ads Targeting Resistant Superbugs Implications for the Future of Antibiotics Tired of too many ads? Remove Ads Next Steps FAQs: In a groundbreaking development, researchers at the Massachusetts Institute of Technology (MIT) have harnessed artificial intelligence (AI) to design two new innovative antibiotics capable of fighting drug-resistant superbugs, including gonorrhoea and MRSA . The method makes a significant step forward in addressing the growing global threat caused by antimicrobial resistance (AMR), which has been explained by the World Health Organization as one of the most urgent public health challenges of the 21st of the newly developed antibiotics has shown remarkable progress against MRSA (methicillin-resistant Staphylococcus aureus), a dangerous pathogen responsible for severe hospital-acquired infections. MRSA is notorious for evading standard antibiotics, leading to prolonged illnesses and higher mortality second compound concentrates on drug-resistant strains of Neisseria gonorrhoeae, the bacterium responsible for gonorrhoea. Rising cases of antibiotic-resistant gonorrhoea have raised serious concerns about treatment failures and broader public health tests confirmed that both compounds successfully killed the targeted bacteria, even those resistant to multiple existing medications. While these results are preliminary, they provide a strong base for further preclinical and clinical successful use of AI in developing these antibiotics signals a new era in drug discovery. By reducing the time and cost involved with developing new drugs, AI could enhance the response to emerging superbugs and other infectious diseases. This is particularly important as the antibiotic pipeline has slowed in recent years, making healthcare systems vulnerable to resistant say that AI-designed antibiotics are not a complete solution but rather an important tool in the ongoing battle against AMR. Complementary strategies, including proper antibiotic stewardship, infection prevention, and global surveillance, remain crucial to handling the spread of resistant aim to advance the new compounds into further preclinical trials to evaluate their safety, efficacy, and side effects in humans. If successful, these antibiotics could provide new treatment for patients affected by resistant infections and save countless lives globally.A1. Superbugs are bacteria resistant to multiple antibiotics, making infections harder to treat. They pose a serious global health risk.A2. AI analyzed vast chemical data to predict molecular structures likely to combat resistant bacteria effectively.
Time of India
a day ago
- Time of India
WHO wants more aid in Gaza before Israeli occupation
Geneva: The UN health agency on Tuesday said Israel should let it stock medical supplies to deal with a "catastrophic" health situation in Gaza before it seizes control of Gaza City. Israel has said its military would "take control" of Gaza City in a plan approved by Prime Minister Benjamin Netanyahu's security cabinet that sparked a wave of global criticism. "We want to stock up, and we all hear about 'more humanitarian supplies are allowed in' -- well it's not happening yet, or it's happening at a way too low a pace," said Rik Peeperkorn, the World Health Organization's representative in the Palestinian territories. Fifty-two percent of medicines were running at zero stock, Peeperkorn said, speaking from Jerusalem. UN agencies warned last month that famine was unfolding in Gaza, with Israel severely restricting aid entry. Peeperkorn said the WHO was able to bring in fewer supplies than it wanted "due to the cumbersome procedures" and products "still denied" entry -- a topic of constant negotiation with the Israeli authorities. "We want to as quickly stock up hospitals... following the news -- the whole discussion about an incursion in Gaza," he said. "We currently cannot do that... We need to be able to get all essential medicines and medical supplies in." Peeperkorn said only 50 percent of hospitals and 38 percent of primary health care centres were functioning, and that too partially. Bed occupancy has reached 240 percent capacity in the Al-Shifa hospital and 300 percent Al-Ahli Hospital in northern Gaza. "The overall health situation remains catastrophic," he said. "Hunger and malnutrition continue to ravage Gaza". Peeperkorn said 148 people died from the effects of malnutrition this year, citing August 5 as the cut-off date. Nearly 12,000 children aged under five were identified to be suffering from acute malnutrition in July -- the highest monthly figure recorded to date in Gaza, Peeperkorn said. These include 2,562 children suffering from severe acute malnutrition, of whom 40 were hospitalised at stabilisation centres.
